Weedmaps Loses $4 Million in Q1 Despite Increase in Clientele

May 9, 2023 · Green Market Report

Several cuts in the second half of 2022 contributed to a 27% improvement in operating costs.

California-based WM Technology Inc., better known as Weedmaps, (Nasdaq: MAPS) shrank its losses to $3.9 million for the first quarter of 2023, from more than $31 million lost in the first quarter a year ago, while also increasing its client base by 12% compared to the same time period.

Weedmaps’ monthly paying client list increased to 5,641 from 5,026 in the first quarter 2022, the company reported, but average monthly revenue per client plunged 25% from a year ago, to $2,837.

But getting financial losses under control – following total losses of nearly $83 million last year – was enough for Executive Chairman Doug Francis to say he was “pleased” with the first quarter of 2023.

The Q1 losses of just under $4 million “reflect the strategic actions we have taken since November to improve our bottom line,” Francis said in a press release.

Weedmaps not only had two rounds of layoffs last year, but longtime CEO Chris Beals also stepped aside in November, which is when Francis took the reins and began focusing on a return to profitability.

“Our continued focus on our marketplace experience and commitment to delivering value to our clients is generating business stability despite end markets that remain challenged,” Francis said, adding that the company’s balance sheet remains “as strong as it’s been in some time,” with $25.9 million in the bank and no long-term debt.

Francis also noted that the recent April 20 holiday, following the end of the first quarter, was a boon to Weedmaps, with a record-breaking number of online orders placed with dispensary partners, according to the company.

Still, Weedmaps is carrying $190 million in total liabilities, the company reported, with the same amount in total assets. Revenues were down year-over-year for Q1 by 16%, to $48 million from $57.4 million a year ago, but operating expenses also were slashed under Francis’ watch by 27%, to $52.1 million from $71.7 million a year prior.

According to guidance in the Q1 report, Weedmaps expects revenues to remain consistent with Q1 for the rest of the year. (Full Story)

In category:Business
Next Post

Green Market Report Women’s Leadership Awards: Kassia Graham

Graham sees opportunity for both legacy operators and newcomers, but warns against opportunists. Social Impact: Kassia Graham, Cannaclusive Kassia Graham, a vocal advocate for diversity and equity in the cannabis industry, is using her platform to affect change. As the…
Previous Post

Illinois Cannabis Sales Stall in April

Declining prices and out-of-state competition hurt the state's industry. This story was republished with permission by Crain’s Chicago and written by John Pletz.  Illinois marijuana sales growth flattened last month for the first time since the state legalized recreational cannabis in 2020, hurt…
Random Post

MindMed Board Battle Continues with Competing Shareholder Bids

Both parties accused each other of not understanding FDA processes. After psychedelic drug company Mind Medicine (Nasdaq: MNMD) released a detailed letter to shareholders pushing back against an attempted board coup by a company called FCM MM Holdings, FCM responded…
Random Post

NBA Releases Details on New Cannabis Policy

The National Basketball Association has confirmed reports that it will permanently end its ban on cannabis, but refuted claims that players would be allowed to promote marijuana brands.  The National Basketball Association (NBA) last week clarified its new cannabis policy…
Random Post

Texas Trip: The future of psychedelic therapy was a hot topic at SXSW 2023

Although the topics at Austin's annual SXSW festival tend to skew toward tech and pop culture, this year's was awash in discussions on the future of psychedelic therapy. At least 20 separate keynote speaker sessions addressed the topic, ranging from…
Random Post

Reaching Medical Cannabis Consumers: Helping Patients Thrive

In a time when adult-use cannabis seems to get all the attention, it’s important to remember that many people use the plant as medicine. There are millions of medical cannabis patients across the country, but this demographic is often cast aside as…